I mentioned SAMR because there is a similar distinction between facility approval and product approval, which some may already be familiar with.
Also, the fact that BUB have failed to achieve SAMR product approval perhaps explains why they have been more proactive in regards to the USA market. I don't follow BUB that closely and I'm not sure if they have even applied for it. If you are classing me as a rusted on A2M holder, OK, but I've been critical of their USA strategy for years, and equally impressed by BUB's initiative on that front, so I am not really sure what your beef is.
A2 Managment has Baby Nap... while Bubs Australia ships 27.5 Million Formula Bottles to U.S, page-164
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.61 |
Change
-0.020(0.36%) |
Mkt cap ! $4.061B | |||
| Open | High | Low | Value | Volume |
| $5.69 | $5.74 | $5.60 | $10.03M | 1.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4199 | $5.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.64 | 2719 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |